Steris PLC (STE) Position Lessened by DF Dent & Co. Inc.

DF Dent & Co. Inc. trimmed its holdings in shares of Steris PLC (NYSE:STE) by 17.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 753,492 shares of the medical equipment provider’s stock after selling 156,274 shares during the quarter. Steris accounts for approximately 1.7% of DF Dent & Co. Inc.’s portfolio, making the stock its 29th biggest position. DF Dent & Co. Inc. owned about 0.89% of Steris worth $66,609,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of STE. Zions Bancorporation acquired a new position in Steris in the 3rd quarter valued at about $178,000. Citigroup Inc. purchased a new position in shares of Steris in the 2nd quarter valued at about $206,000. Van Cleef Asset Management Inc purchased a new position in shares of Steris in the 2nd quarter valued at about $208,000. Cigna Investments Inc. New purchased a new position in shares of Steris in the 2nd quarter valued at about $209,000. Finally, BT Investment Management Ltd purchased a new position in shares of Steris in the 2nd quarter valued at about $210,000. 89.45% of the stock is owned by hedge funds and other institutional investors.

Several equities analysts have recently issued reports on STE shares. Zacks Investment Research cut Steris from a “buy” rating to a “sell” rating in a research note on Monday, November 6th. KeyCorp reiterated a “buy” rating and issued a $91.00 price objective on shares of Steris in a research note on Tuesday, October 17th. Raymond James Financial lifted their price objective on Steris from $95.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Finally, TD Securities boosted their target price on Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research note on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $79.50.

Steris PLC (STE) traded down $0.62 during mid-day trading on Tuesday, reaching $87.83. The company had a trading volume of 417,000 shares, compared to its average volume of 457,713. The stock has a market capitalization of $7,522.88, a PE ratio of 22.80 and a beta of 1.27. Steris PLC has a 12-month low of $65.26 and a 12-month high of $93.39. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.18 and a current ratio of 2.80.

Steris (NYSE:STE) last released its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 EPS for the quarter, missing the consensus estimate of $0.95 by ($0.01). The firm had revenue of $634.20 million for the quarter, compared to analyst estimates of $629.02 million. Steris had a return on equity of 11.49% and a net margin of 5.59%. The company’s quarterly revenue was down 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.89 EPS. research analysts predict that Steris PLC will post 4.06 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 20th. Shareholders of record on Wednesday, November 22nd will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.41%. The ex-dividend date is Tuesday, November 21st. Steris’s dividend payout ratio (DPR) is 73.81%.

In other Steris news, insider Michael J. Tokich sold 12,000 shares of Steris stock in a transaction that occurred on Wednesday, October 4th. The stock was sold at an average price of $89.75, for a total transaction of $1,077,000.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP John Adam Zangerle sold 3,650 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $88.00, for a total value of $321,200.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 36,650 shares of company stock worth $3,315,200. 2.55% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Steris PLC (STE) Position Lessened by DF Dent & Co. Inc.” was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with's FREE daily email newsletter.

Leave a Reply